These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 22386300)
1. Psychometric properties of the CAST and SDS scales in young adult cannabis users. Cuenca-Royo AM; Sánchez-Niubó A; Forero CG; Torrens M; Suelves JM; Domingo-Salvany A Addict Behav; 2012 Jun; 37(6):709-15. PubMed ID: 22386300 [TBL] [Abstract][Full Text] [Related]
2. Optimal scaling of the CAST and of SDS Scale in a national sample of adolescents. Bastiani L; Siciliano V; Curzio O; Luppi C; Gori M; Grassi M; Molinaro S Addict Behav; 2013 Apr; 38(4):2060-7. PubMed ID: 23396173 [TBL] [Abstract][Full Text] [Related]
3. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. Martin G; Copeland J; Gates P; Gilmour S Drug Alcohol Depend; 2006 Jun; 83(1):90-3. PubMed ID: 16310973 [TBL] [Abstract][Full Text] [Related]
4. The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis. Hides L; Dawe S; Young RM; Kavanagh DJ Addiction; 2007 Jan; 102(1):35-40. PubMed ID: 17207121 [TBL] [Abstract][Full Text] [Related]
5. Validation of the Cannabis Abuse Screening Test in a sample of cannabis inpatients. Legleye S; Kraus L; Piontek D; Phan O; Jouanne C Eur Addict Res; 2012; 18(4):193-200. PubMed ID: 22472963 [TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents. Legleye S; Piontek D; Kraus L Drug Alcohol Depend; 2011 Jan; 113(2-3):229-35. PubMed ID: 20869178 [TBL] [Abstract][Full Text] [Related]
7. Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria. Degenhardt L; Coffey C; Carlin JB; Swift W; Patton GC Drug Alcohol Depend; 2008 Jan; 92(1-3):86-90. PubMed ID: 17716830 [TBL] [Abstract][Full Text] [Related]
8. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults. Bashford J; Flett R; Copeland J Addiction; 2010 Apr; 105(4):615-25. PubMed ID: 20403014 [TBL] [Abstract][Full Text] [Related]
9. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting]. Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408 [TBL] [Abstract][Full Text] [Related]
10. The Adolescent Cannabis Problems Questionnaire (CPQ-A): psychometric properties. Martin G; Copeland J; Gilmour S; Gates P; Swift W Addict Behav; 2006 Dec; 31(12):2238-48. PubMed ID: 16626880 [TBL] [Abstract][Full Text] [Related]
11. Properties of the Cannabis Abuse Screening Test (CAST) in the general population. Legleye S; Guignard R; Richard JB; Ludwig K; Pabst A; Beck F Int J Methods Psychiatr Res; 2015 Jun; 24(2):170-83. PubMed ID: 26077195 [TBL] [Abstract][Full Text] [Related]
12. Reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in frequent cannabis users. van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M Int J Methods Psychiatr Res; 2013 Jun; 22(2):138-43. PubMed ID: 23670783 [TBL] [Abstract][Full Text] [Related]
13. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue? Budney AJ Addiction; 2006 Sep; 101 Suppl 1():125-33. PubMed ID: 16930169 [TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the Spanish version of the Cannabis Use Problems Identification Test among Chilean university students: A validation study. Cantillano V; Del Villar P; Contreras L; Martínez D; Zuzulich MS; Ramírez C; Pons C; Bashford J Drug Alcohol Depend; 2017 Jan; 170():32-36. PubMed ID: 27866060 [TBL] [Abstract][Full Text] [Related]
15. An assessment of the compatibility of DSM-IV and proposed DSM-5 criteria in the diagnosis of cannabis use disorders. Kopak AM; Proctor SL; Hoffmann NG Subst Use Misuse; 2012 Oct; 47(12):1328-38. PubMed ID: 22924474 [TBL] [Abstract][Full Text] [Related]
16. Utility of the Brief Symptom Inventory (BSI) in psychiatric outpatients with intellectual disabilities. Wieland J; Wardenaar KJ; Fontein E; Zitman FG J Intellect Disabil Res; 2012 Sep; 56(9):843-53. PubMed ID: 21726320 [TBL] [Abstract][Full Text] [Related]
17. The DSM Guided Cannabis Screen (DSM-G-CS): description, reliability, factor structure and empirical scoring with a clinical sample. Alexander D; Leung P Addict Behav; 2011 Nov; 36(11):1095-100. PubMed ID: 21741769 [TBL] [Abstract][Full Text] [Related]
18. The Cannabis Problems Questionnaire: factor structure, reliability, and validity. Copeland J; Gilmour S; Gates P; Swift W Drug Alcohol Depend; 2005 Dec; 80(3):313-9. PubMed ID: 15916867 [TBL] [Abstract][Full Text] [Related]
19. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10). Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162 [TBL] [Abstract][Full Text] [Related]
20. The Cannabis Abuse Screening Test and the DSM-5 in the general population: Optimal thresholds and underlying common structure using multiple factor analysis. Legleye S Int J Methods Psychiatr Res; 2018 Jun; 27(2):e1597. PubMed ID: 29124816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]